Patents by Inventor Jochen Ringe

Jochen Ringe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190100727
    Abstract: According to the invention fibroblast-like cells obtained from heart muscle biopsies, which are CD90 negative, CD105 positive, CD117 negative and/or CD166 positive as well as cell preparations of such cells for therapy of heart diseases as well as a method for providing the latter are disclosed. The cells according to the invention are characterized by a good cultivability in cell culture. Furthermore a method for obtaining the cells and cell preparations according to the invention are disclosed.
    Type: Application
    Filed: September 30, 2018
    Publication date: April 4, 2019
    Applicant: Charite Universitatsmedizin Berlin
    Inventors: Marion Haag, Jochen Ringe, Michael Sittinger, Carsten Tschope
  • Patent number: 9539297
    Abstract: The present invention relates to a composition comprising, or consisting of 2-50 mg/ml hyaluronic acid, 0.1-500 mg/ml of biodegradable particles with an average mean particle diameter of 1 nm-500 ?m, 1 pg/ml-10 ?g/ml cytokines, where the concentrations specified are based in each case on the total volume (w/v) of the composition and where the cytokines are enclosed in the biodegradable particles, and to their use in the treatment of cartilage defects, for example traumatic cartilage defects or osteoarthrosis.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: January 10, 2017
    Assignee: CHARITE—UNIVERSITATSMEDIZIN BERLIN
    Inventors: Kristin Andreas, Jochen Ringe, Michael Sittinger
  • Publication number: 20150175970
    Abstract: Fibroblast-like cells obtained from heart muscle biopsies, which are CD90 negative, CD105 positive, CD117 negative and/or CD166 positive as well as cell preparations of such cells for therapy of heart diseases, as well as a method for providing the latter. The cells are characterized by a good cultivability in cell culture. Furthermore a method for obtaining the cells and cell preparations according to the invention are disclosed.
    Type: Application
    Filed: March 10, 2015
    Publication date: June 25, 2015
    Applicant: Charite Universitatsmedizin Berlin
    Inventors: Marion Haag, Jochen Ringe, Michael Sittinger, Carsten Tschope
  • Publication number: 20130337074
    Abstract: The present invention relates to a composition comprising, or consisting of 2-50 mg/ml hyaluronic acid, 0.1-500 mg/ml of biodegradable particles with an average mean particle diameter of 1 nm-500 ?m, 1 pg/ml-10 ?g/ml cytokines, where the concentrations specified are based in each case on the total volume (w/v) of the composition and where the cytokines are enclosed in the biodegradable particles, and to their use in the treatment of cartilage defects, for example traumatic cartilage defects or osteoarthrosis.
    Type: Application
    Filed: November 30, 2011
    Publication date: December 19, 2013
    Inventors: Kristin Andreas, Jochen Ringe, Michael Sittinger
  • Publication number: 20100040587
    Abstract: Fibroblast-like cells obtained from heart muscle biopsies, which are CD90 negative, CD105 positive, CD117 negative and/or CD166 positive as well as cell preparations of such cells for therapy of heart diseases, as well as a method for providing the latter. The cells are characterized by a good cultivability in cell culture. Furthermore a method for obtaining the cells and cell preparations according to the invention are disclosed.
    Type: Application
    Filed: August 20, 2009
    Publication date: February 18, 2010
    Applicant: CHARITE-UNIVERSITATSMEDIZIN BERLIN
    Inventors: Marion Haag, Jochen Ringe, Michael Sittinger, Carsten Tschope
  • Publication number: 20070020230
    Abstract: The present invention relates to the use of chemokines and/or nucleic acids encoding a chemokine for recruiting mesenchymal precursor and/or stem cells in vivo and in vitro. The present invention also relates to pharmaceutical preparations which comprise these substances and which are preferably intended for recruiting mesenchymal precursor and/or stem cells for tissue synthesis.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 25, 2007
    Inventors: Christian Kaps, Jochen Ringe